Annual EBIT
-$4.12M$29.93M+87.89%
Summary
- Current Value
- As of today, DVAX annual EBIT is -$4.12M, up +87.89% on
- Historical Performance
- DVAX annual EBIT is down -103.10% over the past 3 years, and up +96.54% over the past 5 years
- All-Time High Comparison
- DVAX annual EBIT is currently -101.45% below its historical high of $284.75M set on
- 3-Year Low Comparison
- DVAX annual EBIT is +87.89% above its 3-year low of -$34.05M reached on
- Sector Comparison
- DVAX annual EBIT is higher than 72.25% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$4.12M | +87.9% | -103.1% | +96.5% | +72.7% | |
| Quarterly EBIT | $21.27M | +111.0% | -65.6% | +206.6% | +415.1% | |
| TTM EBIT | $10.44M | +240.2% | -96.5% | +111.9% | +124.0% | |
| Price | $15.41 | +22.1% | +50.0% | +208.8% | -52.9% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $277.25M | +19.4% | -36.6% | +687.2% | +587.6% | |
| Annual EPS | $0.20 | +512.9% | -62.2% | +109.5% | +102.7% | |
| Annual EBITDA | $3.93M | +114.7% | -97.2% | +104.0% | +132.0% | |
| Annual Net Income | $27.31M | +527.4% | -62.1% | +117.9% | +280.5% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $284.75M | N/A | -101.5% |
| 5Y | $284.75M | -101.5% | |
| All | $284.75M | -101.5% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$34.05M | +87.9% | |
| 5Y | -$75.22M | N/A | +94.5% |
| All | -$150.53M | +97.3% |
EBIT History
FAQ
What is the current annual EBIT of DVAX?
As of today, DVAX annual EBIT is -$4.12M
What is 1-year change in DVAX annual EBIT?
DVAX annual EBIT is up +87.89% year-over-year
What is 3-year change in DVAX annual EBIT?
DVAX annual EBIT is down -103.10% over the past 3 years
How far is DVAX annual EBIT from its all-time high?
DVAX annual EBIT is currently -101.45% below its historical high of $284.75M set on December 31, 2022
How does DVAX annual EBIT rank versus sector peers?
DVAX annual EBIT is higher than 72.25% of companies in Healthcare sector
When is DVAX next annual earnings release?
The next annual earnings release for DVAX is on
Quarterly EBIT
$21.27M$6.84M+47.42%
Summary
- Current Value
- As of today, DVAX quarterly EBIT is $21.27M, up +47.42% on
- Historical Performance
- DVAX quarterly EBIT is up +110.98% year-over-year, and down -65.60% over the past 3 years
- All-Time High Comparison
- DVAX quarterly EBIT is currently -83.34% below its historical high of $127.67M set on
- 3-Year Low Comparison
- DVAX quarterly EBIT is +172.00% above its 3-year low of -$29.54M reached on
- Sector Comparison
- DVAX quarterly EBIT is higher than 85.19% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $21.27M | +47.4% | +111.0% | -65.6% | +206.6% | |
| Annual EBIT | -$4.12M | – | +87.9% | -103.1% | +96.5% | |
| TTM EBIT | $10.44M | +1489.9% | +240.2% | -96.5% | +111.9% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $94.88M | -0.6% | +17.7% | -43.4% | +607.3% | |
| Quarterly EPS | $0.21 | +52.5% | +81.6% | -52.0% | +237.2% | |
| Quarterly EBITDA | $23.37M | +41.9% | +92.5% | -63.1% | +228.3% | |
| Quarterly Net Income | $26.93M | +43.8% | +53.0% | -57.8% | +511.8% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $21.27M | at high | |
| 3Y | $63.77M | N/A | -66.6% |
| 5Y | $127.67M | -83.3% | |
| All | $127.67M | -83.3% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$23.63M | +190.0% | |
| 3Y | -$29.54M | +172.0% | |
| 5Y | -$29.54M | +172.0% | |
| All | -$38.44M | +155.3% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of DVAX?
As of today, DVAX quarterly EBIT is $21.27M
What is DVAX quarterly EBIT most recent change?
DVAX quarterly EBIT was up +47.42% on September 30, 2025
What is 1-year change in DVAX quarterly EBIT?
DVAX quarterly EBIT is up +110.98% year-over-year
How far is DVAX quarterly EBIT from its all-time high?
DVAX quarterly EBIT is currently -83.34% below its historical high of $127.67M set on June 30, 2022
How does DVAX quarterly EBIT rank versus sector peers?
DVAX quarterly EBIT is higher than 85.19% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
TTM EBIT
$10.44M$11.19M+1,489.88%
Summary
- Current Value
- As of today, DVAX TTM EBIT is $10.44M, up +1489.88% on
- Historical Performance
- DVAX TTM EBIT is up +240.24% year-over-year, and down -96.54% over the past 3 years
- All-Time High Comparison
- DVAX TTM EBIT is currently -96.54% below its historical high of $301.69M set on
- 3-Year Low Comparison
- DVAX TTM EBIT is +130.66% above its 3-year low of -$34.05M reached on
- Sector Comparison
- DVAX TTM EBIT is higher than 79.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $10.44M | +1489.9% | +240.2% | -96.5% | +111.9% | |
| Annual EBIT | -$4.12M | – | +87.9% | -103.1% | +96.5% | |
| Quarterly EBIT | $21.27M | +47.4% | +111.0% | -65.6% | +206.6% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $330.51M | +4.5% | +26.7% | -54.9% | +779.7% | |
| TTM EPS | -$0.38 | +19.5% | -393.3% | -116.7% | +69.8% | |
| TTM EBITDA | $18.68M | +150.8% | +3665.7% | -94.0% | +124.6% | |
| TTM Net Income | -$43.40M | +17.7% | -311.9% | -113.5% | +55.0% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $10.44M | at high | |
| 3Y | $284.75M | N/A | -96.3% |
| 5Y | $301.69M | -96.5% | |
| All | $301.69M | -96.5% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$9.12M | +214.4% | |
| 3Y | -$34.05M | +130.7% | |
| 5Y | -$73.18M | N/A | +114.3% |
| All | -$150.75M | +106.9% |
TTM EBIT History
FAQ
What is the current TTM EBIT of DVAX?
As of today, DVAX TTM EBIT is $10.44M
What is DVAX TTM EBIT most recent change?
DVAX TTM EBIT was up +1489.88% on September 30, 2025
What is 1-year change in DVAX TTM EBIT?
DVAX TTM EBIT is up +240.24% year-over-year
How far is DVAX TTM EBIT from its all-time high?
DVAX TTM EBIT is currently -96.54% below its historical high of $301.69M set on September 30, 2022
How does DVAX TTM EBIT rank versus sector peers?
DVAX TTM EBIT is higher than 79.30% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
EBIT Formula
EBIT = − −
Data Sources & References
- DVAX Official Website www.dynavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1029142/000162828025049536/0001628280-25-049536-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1029142/000102914225000049/0001029142-25-000049-index.htm
- DVAX Profile on Yahoo Finance finance.yahoo.com/quote/DVAX
- DVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dvax